Your Voice for Health

Legislative Issues and Advocacy Alerts

Action Alerts Get Informed! Get Involved!

CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced

Posted November 20, 2020
Pharmaceutical company Pfizer, Inc. announced on Nov. 9, 2020 that ongoing Phase 3 clinical trial of its COVID-19 mRNA vaccine candidate suggests the vaccine may be 90 percent effective in preventing infection with the SARS-CoV-2 virus. The news sent Pfizer’s stock price surging to a high of $41.99 per share and earned CEO Albert Bourla $5.6 million when he sold 60 percent of his holdings (132,508 shares) at $41.94 per share on the same day.  Read more.

  • Home
  • Action Alerts
  • Get Informed On . . .
    • Genetically Modified Organisms (GMOs)
    • Foods
    • Health and Wellness
    • Vaccines
    • Drugs
    • Dietary Supplements
    • Disease
    • Chemicals
    • Videos
    • U.S. Legislation
    • International Legislation
  • Books and Videos
  • Get Involved!
  • About Us
  • FAQs
  • Online Resources
  • Send an Email
Silence is Acceptance.
Speak Out!
Share

Copyright © 2021 · Log in Another idiStudio.com website design.